View Older Stories View More Recent Stories

Apr 5, 2023 08:00AM Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change
Mar 29, 2023 07:09PM AUNA ANNOUNCES SIGNING OF US$505 MILLION FINANCING
Mar 27, 2023 04:34PM Form SC 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Mar 27, 2023 09:11AM The $15 billion scramble for Japan's Toshiba went from bang to whimper
Mar 24, 2023 01:34PM Form SC 13D Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
Mar 20, 2023 04:40PM Form SC 13D EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Mar 15, 2023 04:55PM Form SC 13D/A Atento S.A. Filed by: FARALLON CAPITAL MANAGEMENT LLC
Mar 10, 2023 11:10AM Form D/A Farallon Capital Partner
Mar 10, 2023 11:09AM Form D/A FARALLON CAPITAL OFFSHOR
Mar 10, 2023 11:07AM Form D/A Farallon Capital Institu
Mar 10, 2023 11:07AM Form D/A Farallon Capital (AM)
Feb 17, 2023 03:21PM Form SC 13G AVROBIO, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 14, 2023 05:16PM 'Big Short' manager Burry, Farallon among hedge funds making bets on China
Feb 14, 2023 10:27AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 14, 2023 10:11AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 14, 2023 09:52AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Feb 14, 2023 08:28AM Form SC 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Feb 14, 2023 08:12AM Form 13F-NT Farallon Capital Europe For: Dec 31
Feb 14, 2023 08:11AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
Feb 9, 2023 04:56PM Form SC 13G/A Shelter Acquisition Corp Filed by: Farallon Capital Partners, L.P.
Feb 9, 2023 04:55PM Form SC 13G/A Protagonist Therapeutics Filed by: Farallon Capital Partners, L.P.
Feb 9, 2023 04:55PM Form SC 13G/A Swiftmerge Acquisition Filed by: Farallon Capital Partners, L.P.
Feb 9, 2023 04:54PM Form SC 13G/A Clever Leaves Holdings Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 7, 2023 05:12PM Form SC 13G/A Metals Acquisition Corp Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 7, 2023 05:11PM Form SC 13G/A SDCL EDGE Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 7, 2023 05:10PM Form SC 13G/A CLARIVATE Plc Filed by: Farallon Capital Partners, L.P.
Feb 7, 2023 05:10PM Form SC 13G/A Better Therapeutics, Filed by: Farallon Capital Partners, L.P.
Feb 7, 2023 05:09PM Form SC 13G/A AMYRIS, INC. Filed by: Farallon Capital Partners, L.P.
Feb 6, 2023 04:20PM Form SC 13G/A SEP Acquisition Corp. Filed by: Farallon Capital Partners, L.P.
Feb 6, 2023 04:20PM Form SC 13G/A Marblegate Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 6, 2023 04:19PM Form SC 13G/A Inflection Point Acquisi Filed by: FARALLON CAPITAL MANAGEMENT LLC
Feb 6, 2023 09:09AM Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: Farallon Capital Partners, L.P.
Feb 3, 2023 05:17PM Form SC 13G/A Savara Inc. Filed by: Farallon Capital Partners, L.P.
Feb 3, 2023 05:16PM Form SC 13G/A Longboard Pharmaceutical Filed by: Farallon Capital Partners, L.P.
Feb 3, 2023 05:15PM Form SC 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
Feb 1, 2023 05:17PM Form SC 13G/A Imago BioSciences, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 1, 2023 05:12PM Form SC 13G/A Generation Bio Co. Filed by: Farallon Capital Partners, L.P.
Feb 1, 2023 05:10PM Form SC 13G/A Big Sky Growth Partners, Filed by: Farallon Capital Partners, L.P.
Jan 31, 2023 05:18PM Form SC 13G/A Disruptive Acquisition Filed by: Farallon Capital Partners, L.P.
Jan 31, 2023 05:15PM Form SC 13G/A Berenson Acquisition Filed by: Farallon Capital Partners, L.P.
Jan 31, 2023 05:10PM Form SC 13G/A ARYA Sciences Acquisitio Filed by: Farallon Capital Partners, L.P.
Jan 5, 2023 07:00AM Metagenomi Closes Oversubscribed Series B Financing Totaling $275M to Advance Lead Therapeutic Programs into Clinical Development and Grow Genetic Medicines Pipeline
Dec 16, 2022 05:15PM Form SC 13G/A Marblegate Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
Nov 21, 2022 08:30AM FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers
Nov 16, 2022 07:28AM Alvotech (ALVO) Secures $136M in Financing Facilities
Nov 16, 2022 07:27AM Alvotech Secures Financing Facilities of Approximately $136 Million
Nov 16, 2022 07:26AM Alvotech Secures Financing Facilities of Approximately $136 Million
Nov 14, 2022 04:04PM Farallon, Franklin Templeton among potential winners in Twitter
Nov 14, 2022 12:47PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2022 12:31PM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
View More Recent Stories View Older Stories